Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02971501
Title Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles General Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Keck Medical Center of USC Pasadena Pasadena California 91105 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
Smilow Cancer Center/Yale-New Haven Hospital New Haven Connecticut 06510 United States Details
Yale University New Haven Connecticut 06520 United States Details
Moffitt Cancer Center-International Plaza Tampa Florida 33607 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Kansas Clinical Research Center Fairway Kansas 66205 United States Details
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205 United States Details
Nebraska Medicine-Bellevue Bellevue Nebraska 68123 United States Details
Nebraska Medicine-Village Pointe Omaha Nebraska 68118 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field